Overview

Fentanyl Sublingual Spray in Opioid Naive Participants

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to determine the pharmacokinetic and pharmacodynamic relationship of multiple dose administration of fentanyl sublingual spray in opioid naive participants. The secondary objective is to determine the safety and tolerability of multiple dose administration of fentanyl sublingual spray in opioid naive subjects.
Phase:
Phase 1
Details
Lead Sponsor:
INSYS Therapeutics Inc
Treatments:
Citric Acid
Fentanyl